Marchés/ActionsArticle

Lilly to present cardiometabolic drug data at EASD conference

Eli Lilly will present cardiometabolic drug data at the upcoming EASD conference.

PA

Priya Anand · Equities & Earnings Desk · 15 Sept 2026 · 12:21 · 1 min de lecture

Lilly to present cardiometabolic drug data at EASD conference

Eli Lilly announced it will present cardiometabolic drug data at the EASD conference.

Further details were not immediately available.

Companies Healthcare

Cet article a été produit avec l'assistance de l'IA et édité par un journaliste de Finance Review Daily.

Novara — A Smarter Way to Access Global Markets

Partager cet article

PA

Par

Priya Anand

Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

Plus de Priya Anand →

Aperçu du marché

Différé

EUR/USD1.1535▼ 0.14%GBP/USD1.3482▼ 0.14%USD/CHF0.8178▲ 0.06%BTC/USD77,038.3▼ 1.47%ETH/USD2,475.26▼ 1.61%XAU/USD4,274.82▼ 0.55%

Beximco Pharmaceuticals eyes board shake-up in bid to settle Bangladesh court disputes

Priya Anand · il y a 43 min

Lilly to present cardiometabolic drug data at EASD conference

Aperçu du marché

À lire aussi

Big Ridge Gold Names Ex-Maritime Resources CEO Garett Macdonald to Board

Driven Brands Sets 2-3x Leverage Target, Authorizes $100M Buyback

Brunswick sees strong dealer demand at Cannes boat show

Kromek Chairman Buys 145K Shares at 6.88p

Beximco Pharmaceuticals eyes board shake-up in bid to settle Bangladesh court disputes